Project documents | Tanezumab for treating moderate to severe chronic pain caused by osteoarthritis [ID1603] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final stakeholder list (PDF 153 KB)

Published:

26 October 2020
Final scope (PDF 164 KB)

Published:

26 October 2020
Equality impact assessment (Scoping) (PDF 123 KB)

Published:

27 October 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 174 KB)

Published:

03 August 2020
Draft matrix post referral (PDF 151 KB)

Published:

03 August 2020